These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8212841)

  • 21. Antibody assays suitable for assessing immune responses to live varicella vaccine.
    Provost PJ; Krah DL; Kuter BJ; Morton DH; Schofield TL; Wasmuth EH; White CJ; Miller WJ; Ellis RW
    Vaccine; 1991 Feb; 9(2):111-6. PubMed ID: 1647574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
    Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
    Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice.
    Zhu R; Liu J; Chen C; Ye X; Xu L; Wang W; Zhao Q; Zhu H; Cheng T; Xia N
    Vaccine; 2016 Mar; 34(13):1589-1596. PubMed ID: 26873057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and purification of varicella-zoster virus glycoprotein I gene in insect cells].
    Guo LZ; Lu XY; Xiang JZ; Zhang YH; Guo CS; Zhang PF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Nov; 37(6):442-5. PubMed ID: 14703502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
    Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
    Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.
    Bennett AM; Slomka MJ; Brown DW; Lloyd G; Mackett M
    J Med Virol; 1999 Jan; 57(1):47-56. PubMed ID: 9890421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N
    Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIV.
    Vafai A; Jensen K; Kubo R
    Virus Res; 1989 Aug; 13(4):319-36. PubMed ID: 2479191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
    Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
    Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.
    Haumont M; Jacquet A; Massaer M; Deleersnyder V; Mazzu P; Bollen A; Jacobs P
    Virus Res; 1996 Feb; 40(2):199-204. PubMed ID: 8725116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
    Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
    Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.
    Oliver SL; Yang E; Arvin AM
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR; Grose C
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions.
    Shankar V; Fisher S; Forghani B; Vafai A
    Vaccine; 2001 Jul; 19(28-29):3830-3. PubMed ID: 11427254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.